共 52 条
[11]
Berke G., Rosen D., Highly lytic in rtm primed CTL devoid of lylic granules and BLT‐esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vivo, J. Immunol, 141, pp. 1429-1436, (1988)
[12]
Berke G, Rosen D, Ronen D., Mechanism of lymphocyte‐mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes, Immunology, 78, pp. 105-112, (1993)
[13]
Berke G., Sullivan K.A., Amos D.B., Rejection of ascites tumor allografts. 1 Isolation, characterization and in vitro reactivity of peritoneal lymphoid effector cells from BALB/c mice immune to EL4 leukoasis, J. Exp. Med, 135, pp. 1334-1350, (1972)
[14]
Berke G., Sullivan K.A., Amos D.B., Rejection of ascites tumor allograft. IL A pathway for cell‐mediated tumor destruction in vitro by peritoneal exudate lymphoid cells, J. Exp. Med, 136, pp. 1594-1604, (1972)
[15]
Berke G., Tzur R., Inbar M., Changes in fluorescence polarization of a membrane probe during lymphocyte‐target cell interaction, J. Immunol, 120, pp. 137-1384, (1978)
[16]
Berke G., Yagil G., Ginsburg H., Feldman M., Kinetic analysis of a graft reaction induced in cell culture, Immunology, 17, pp. 723-740, (1969)
[17]
Boldin M.P., Mett I.L., Varfolomeev E.E., Chumakov I., Shemar-Avni Y., Camonis J.H., Wallach D., Self‐association of the “Death Domains” of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APOl Prompts Signaling for TNF and Fas/APOl Effects*, J. Biol. Client, 270, pp. 387-391, (1995)
[18]
Clark W.R., Berke G., Feldman M., Sarid S., Macromolecular synthesis during the sensilization of rat lymphocytes on mouse fibroblasts in vivo, Immunochemistry, 8, pp. 487-498, (1971)
[19]
Dourmashkin R.R., Deteix F., Simone C.M., Henkart P., Electron microscopic demonstration of lesions on target cell membranes associated with antibody‐dependent cellular cylotoxicity, Clin. Exp. Immunol, 42, pp. 554-560, (1980)
[20]
Engelmann H., Holtmann H., Brakebusch C., Avni Y.S., Sarov J., Nophar Y., Hadas E., Leitner O, Wallach D., Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF‐like activity, J. Biol. Chem, 265, pp. 14497-14504, (1990)